deltatrials
Completed OBSERVATIONAL NCT04027868

Genomic BRCA and Extensive ovArian Cancer Testing (GREAT)

Cohort Study to Evaluate the Clinical Features of Patients With Epithelial Ovarian Cancer Depending on Tumoral Mutation of BRCA or Beyond BRCA Genomic Molecular Abnormalities

Sponsor: ARCAGY/ GINECO GROUP

Conditions Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer
Updated 22 times since 2019 Last updated: Feb 13, 2026 Started: Dec 6, 2019 Primary completion: Nov 7, 2022 Completion: Nov 7, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04027868, this observational or N/A phase trial focuses on Epithelial Ovarian Cancer and Fallopian Tube Cancer and remains completed. Sponsored by ARCAGY/ GINECO GROUP, it has been updated 22 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Feb 2020 · 31 days · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jun 2020 · 2 months · monthly snapshot~Jun 2020 – ~Oct 2020 · 4 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Oct 2023 · 9 months · monthly snapshot~Oct 2023 – ~Jan 2024 · 3 months · monthly snapshot~Jan 2024 – ~Jun 2024 · 5 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 7 months · monthly snapshot

Change History

22 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed

  2. Sep 2025 — Feb 2026 [monthly]

    Completed

  3. Feb 2025 — Sep 2025 [monthly]

    Completed

  4. Sep 2024 — Feb 2025 [monthly]

    Completed

  5. Jul 2024 — Sep 2024 [monthly]

    Completed

▶ Show 17 earlier versions

  1. Jun 2024 — Jul 2024 [monthly]

    Completed

  2. Jan 2024 — Jun 2024 [monthly]

    Completed

  3. Oct 2023 — Jan 2024 [monthly]

    Completed

  4. Jan 2023 — Oct 2023 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

    Status: Recruiting → Completed

  6. Sep 2022 — Dec 2022 [monthly]

    Recruiting

  7. Dec 2021 — Sep 2022 [monthly]

    Recruiting

  8. Feb 2021 — Dec 2021 [monthly]

    Recruiting

  9. Jan 2021 — Feb 2021 [monthly]

    Recruiting

  10. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  11. Oct 2020 — Nov 2020 [monthly]

    Recruiting

  12. Jun 2020 — Oct 2020 [monthly]

    Recruiting

    Status: Active Not Recruiting → Recruiting

  13. Apr 2020 — Jun 2020 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  14. Feb 2020 — Apr 2020 [monthly]

    Recruiting

  15. Jan 2020 — Feb 2020 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  16. Dec 2019 — Jan 2020 [monthly]

    Not Yet Recruiting

  17. Aug 2019 — Dec 2019 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ARCAGY/ GINECO GROUP
  • AstraZeneca
Data source: ARCAGY/ GINECO GROUP

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Agen, France , Aix-en-Provence, France , Amiens, France , Angers, France , Antony, France , Arras, France , Auxerre, France , Avignon, France , Bayonne, France , Beauvais, France and 94 more locations